Parental Autoimmune Diseases Associated With Autism Spectrum Disorders in Offspring by Keil, Alexander et al.
Parental Autoimmune Diseases Associated With Autism
Spectrum Disorders in Offspring
Alexander Keila, Julie L. Danielsa,b, Ulla Forssenc,d, Christina Hultmane, Sven Cnattingiusf,
Karin C. Söderbergg, Maria Feychtingd, and Par Sparene
aDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC
bDepartment of Maternal and Child Health, University of North Carolina, Chapel Hill, NC
cWorldwide Epidemiology, GlaxoSmithKline R&D, Collegeville, PA
dInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
eDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
fClinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
gDivision of Clinical Pharmacology, Karolinska University Hospital Huddinge, Karolinska Institutet,
Stockholm, Sweden
Abstract
Background—Autism spectrum disorders are often idiopathic. Studies have suggested
associations between immune response and these disorders. We explored associations between
parental autoimmune disorders and children’s diagnosis of autism by linking Swedish registries.
Methods—Data for each participant were linked across 3 Swedish registries. The study includes
1227 cases and 25 matched controls for each case (30,693 controls with parental linkage). Parental
diagnoses comprised 19 autoimmune disorders. We estimated odds ratios (ORs) using
multivariable conditional logistic regression.
Results—Parental autoimmune disorder was weakly associated with autism spectrum disorders
in offspring (maternal OR = 1.6 [95% confidence interval = 1.1–2.2]; paternal OR = 1.4 [1.0 –
2.0]). Several maternal autoimmune diseases were correlated with autism. For both parents,
rheumatic fever was associated with autism spectrum disorders.
Conclusions—These data support previously reported associations between parental
autoimmune disorders and autism spectrum disorders. Parental autoimmune disorders may
represent a critical pathway that warrants more detailed investigation.
Autism spectrum disorders comprise a group of developmental disorders defined by a
constellation of behavioral, communication, and social deficits.1 Altered autoimmune
responses have been reported among persons with autism,2,3 as well as among their
parents4–6 and other family members.7 Autoimmune disorders represent specific types of
immune dysfunction in which the immune system activates against self-antigens.
Autoimmune conditions previously reported in association with autism include type 1
diabetes, rheumatoid arthritis, ulcerative colitis, and celiac disease.4–17 Molloy et al18
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reported regressive autism as a subtype that may be more strongly associated with familial
autoimmune disorders. The current study examines associations of maternal and paternal
autoimmune disease with autism spectrum disorders in offspring, using comprehensive data
from Swedish medical records.
METHODS
This study is based on record linkage of the Swedish registry system, described previously
by Daniels et al.19 Briefly, cases were identified as children born between 1977 and 2003
who were diagnosed by age 10 with an autism spectrum disorder (autism, Asperger
syndrome, or pervasive developmental disorder-not otherwise specified) in the Swedish
Hospital Discharge Registry. The Register includes nearly-complete data on hospital
discharges and diagnoses made by the treating physician according to the International
Classification of Diseases (ICD).20 The Swedish health care system includes a strong
network of school health services, inpatient care, and outpatient care.
The children’s diagnostic records were linked to the Swedish Medical Birth Registry,
operated by the National Board of Health and Welfare, using the unique national registration
number assigned to all Swedish residents at the time of birth or immigration. Each case child
was matched by sex, birth year, and birth hospital to 25 living control children in the
Registry who did not have a record of autism spectrum disorders diagnosis.
Among the 1237 cases and 30,925 controls who met all eligibility criteria, 1227 (99%) of
the cases and 30,693 (99%) of the controls were linked to both biologic parents, using the
Swedish Multi-Generation Register. The register assumes paternity for the husband of the
mother at the time of birth or the man identified “by acknowledgment” of unwed mothers.
The Swedish Hospital Discharge Register was used to identify all diagnoses related to
autoimmune disorders for each parent (using ICD Codes) between 1968 and 2003. Parental
autoimmune disorders were classified a priori according to ICD code (eTable,
http://links.lww.com/EDE/A422). Statistics Sweden provided data on parents’ country of
birth and socioeconomic status.
Because most autoimmune disorders are rare, we restricted our analysis of specific
autoimmune conditions to disorders occurring in parents of at least 2 cases. Odds ratios
(ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic
regression, with adjustments for child’s age, sex, and hospital of birth, and for parents’
country of birth and age at delivery. The study was approved by the University of North
Carolina at Chapel Hill Office of Human Research Ethics Institutional Review Board and by
the Karolinska Institutet Research Ethics Committee.
RESULTS
Matching characteristics were similar among autism spectrum disorders cases and controls.
Control parents were younger, more likely to originate from Nordic countries, and less likely
to originate from Asian and African countries than parents of children with autism spectrum
disorders (as noted previously by Daniels et al19). A majority (63%) of the Autism spectrum
disorders cases were diagnosed before 1998, using ICD-9 criteria for diagnosis (Table 1).
Collectively, autoimmune disease in both parents was associated with an increased
likelihood of autism spectrum disorders diagnosis in offspring (for maternal diagnosis OR =
1.6 [95% CI = 1.1–2.2]; for paternal diagnosis, OR = 1.4 [95% CI = 1.0 –2.0]) (Table 2).
Several specific diagnoses among mothers had elevated odds ratios, including type-1
diabetes, idiopathic thrombocytopenic purpura, myasthenia gravis, and rheumatic fever;
Keil et al. Page 2













however, most were quite rare and effect estimates were imprecise. Fewer associations were
noted for fathers.
DISCUSSION
This study supports previous reports that the prevalence of autoimmune disorders is elevated
in families of persons diagnosed with an autism spectrum disorders,18,21 especially for
mothers of children with autism.4–6 This study was large and population-based, and it used
complex record linkages to provide extensive health data on individuals for many years,
which may have avoided some selection and recall issues of earlier studies.
Our results are generally similar to other published studies,4,5 although varying methods,
case definitions, and prevalences of autoimmune disorders limit direct comparison. Two
registry-based studies from Denmark reported elevated prevalence of type-1 diabetes,
ulcerative colitis, and psoriasis among parents of children with autism.6,7 However, one of
these studies relied primarily on a narrower, ICD-8 classification for autism.5,6 The other
was methodologically similar to ours but included only parental disorders that occurred
before children’s diagnoses.7 Another study from the United States also reported an
association between type-1 diabetes mellitus; that study evaluated several additional
maternal autoimmune disorders that were not prevalent in our study.4
There is some concern that childhood disease might be differentially ascertained when
parents have chronic disease. Parents may use health care more frequently, and consequently
may more readily seek care for their child. Such a phenomenon might have a greater impact
in studies that focus on parents’ diagnoses that precede children’s diagnoses. Because some
previous studies rely on person-time at risk to calculate incidence rate ratios, any reduction
in time at risk for children of parents with disease due to accelerated use of health care might
inflate the association. Our study included parental diagnoses that occurred before as well as
after the birth and diagnosis of the child; furthermore, we estimated odds ratios, which were
not subject to differential time at risk.
We were unable to validate each autism spectrum disorders diagnosis in this registry-based
study, unlike the California-based studies.4,10 Nonetheless, the child’s discharge diagnosis in
our Registry represents the final assessment of a psychiatric specialist. During the period of
study, the Swedish Hospital Discharge Register provides nationwide coverage of inpatient
facilities, to which all residents have equal access. Previous estimates suggest the registry
captured approximately 50% of all autism spectrum disorders cases during the study
period.20,22,23 Because the registry is based on hospital diagnoses, milder cases of both child
and parental disorders may be underrepresented. Under-ascertainment of both outcome and
exposure would likely underestimate the effect estimates, although the confluence of these
factors could bias the results in of an unpredictable direction. Finally, we were unable to
identify siblings within this analysis. Clustering within families would not bias our estimated
odds ratios, but it might produce confidence intervals that are too narrow.
There are several plausible pathways by which immune dysfunction might affect autism
spectrum disorders.2,3,24–26 Maternal autoimmunity may influence brain development either
by creating a hostile uterine environment11,12 or by altering the child’s autoimmunity in
early development through immunoglobulin G (IgG), which can pass through the blood-
brain barrier and is partly responsible for maternally-conferred immunity in infancy.10 The
IgG reactivity profiles of children with autism and their mothers have been shown to differ
from controls.8,27–29 Radetti et al30 also described a transplacental pathway by which
maternal auto-antibodies can be introduced into the fetal environment. Animal studies have
shown differential cytokine profiles and autism-like characteristics in offspring induced by
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prenatally exposing mice and rhesus monkeys to a human case-mother’s IgG.11,12,31
Together, these studies suggest that nonspecific autoimmune reactivity in parents, (primarily
mothers) may be related to autism in offspring.11,12,31,32 This literature could be interpreted
in 2 ways: (1) some cases of autism spectrum disorders result from adverse conditions
caused by altered autoimmune response during the prenatal or early postnatal period,
possibly by enhancing susceptibility to other agents, or (2) some familial factors are
concurrently associated with both autism spectrum disorders and autoimmunity.
We observed nearly a 50% higher odds of being diagnosed with autism by age 10 years
among children whose parents had any autoimmune disease. We used a large, representative
sample with extensive, lengthy follow-up of individuals through the registry system. The
overall association was observed for both mothers and fathers, but high odds ratios
estimated for some disorders should be interpreted with caution due to the rarity of each
disorders. Our results support those from smaller studies, although the specific autoimmune
disorders implicated vary by study, possibly a result of methodological differences or
differing burden of specific autoimmune disorders among the source populations. The more
consistently implicated and prevalent disorders, such as type 1 diabetes, warrant more in-
depth investigation. Studies could also explore familial autoimmune conditions among
subclinical autism-related behaviors or the broad autism phenotype.33 Further mechanistic
work should investigate specific etiologic bases for this association.
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   <25 327 (27) 8485 (28)
   26–30 414 (34) 11,450 (37)
   31–35 317 (26) 7511 (24)
   36–40 146 (12) 2783 (9)
   41–50 23 (2) 464 (2)
Paternal age (years)
   <25 128 (10) 4407 (14)
   26–30 346 (28) 9846 (32)
   31–35 385 (32) 9136 (30)
   36–40 226 (18) 4759 (16)
   41–50 125 (10) 2345 (8)
   >50 17 (1) 200 (1)
Maternal country of origin
   Nordic countries 1029 (84) 27,588 (90)
   Europe and North America 59 (5) 1364 (4)
   Africa 42 (3) 403 (1)
   Asia 77 (6) 1016 (3)
   South America 18 (1) 254 (1)
   Other 2 (0.2) 68 (0.2)
Paternal country of origin
   Nordic countries 1013 (83) 27,136 (88)
   Europe and North America 66 (5) 1622 (5)
   Africa 49 (4) 514 (2)
   Asia 82 (7) 1094 (4)
   South America 17 (1) 282 (1)
   Other 0 45 (0.1)
Sex of child
   Boy 939 (77) 23,478 (76)
   Girl 288 (23) 7215 (24)
Age at diagnosis/reference (years)
   1 12 (1) 300 (1)
   2 62 (5) 1562 (5)
   3 0 (14) 4161 (14)
   4 240 (20) 6012 (20)
   5 213 (17) 5286 (17)
   6 158 (13) 3947 (13)
   7 148 (12) 3693 (12)





















   8 88 (7) 2258 (7)
   9 94 (8) 2335 (8)
   10 44 (4) 1139 (4)
Diagnosis
   ICD-10 (diagnosed before 1998) 776 (63)
   ICD-10 (diagnosed in or after 1998) 451 (37)











































































































































































































































































































































































































































































































































































































Epidemiology. Author manuscript; available in PMC 2011 June 15.
